Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Gastrointestinal stromal tumors (GIST): a proposal of a "CT-based predictive model of Miettinen index" in predicting the risk of malignancy.

Mazzei MA, Cioffi Squitieri N, Vindigni C, Guerrini S, Gentili F, Sadotti G, Mercuri P, Righi L, Lucii G, Mazzei FG, Marrelli D, Volterrani L.

Abdom Radiol (NY). 2019 Sep 10. doi: 10.1007/s00261-019-02209-7. [Epub ahead of print]

PMID:
31506758
2.

Childhood infectious diseases and risk of non-Hodgkin's lymphoma according to the WHO classification: A reanalysis of the Italian multicenter case-control study.

Parodi S, Seniori Costantini A, Crosignani P, Fontana A, Miligi L, Nanni O, Piro S, Ramazzotti V, Rodella S, Tumino R, Vindigni C, Vineis P, Stagnaro E.

Int J Cancer. 2019 May 11. doi: 10.1002/ijc.32393. [Epub ahead of print]

PMID:
31077355
3.

MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response.

Barravecchia I, Mariotti S, Pucci A, Scebba F, De Cesari C, Bicciato S, Tagliafico E, Tenedini E, Vindigni C, Cecchini M, Berti G, Vitiello M, Poliseno L, Mazzanti CM, Angeloni D.

Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2111-2124. doi: 10.1016/j.bbadis.2019.04.008. Epub 2019 Apr 18.

PMID:
31004710
4.

Familial aggregation of gastric cancer with microsatellite instability.

Polom K, Marrelli D, Voglino C, Roviello G, De Franco L, Vindigni C, Generali D, Roviello F.

Acta Chir Belg. 2018 Oct;118(5):287-293. doi: 10.1080/00015458.2017.1379789. Epub 2018 Aug 3.

PMID:
30071769
5.

PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene.

Polom K, Marrelli D, Roviello G, Pascale V, Voglino C, Vindigni C, Generali D, Roviello F.

Adv Clin Exp Med. 2018 Jul;27(7):963-969. doi: 10.17219/acem/70795.

6.

Childhood infectious diseases and risk of multiple myeloma: an analysis of the Italian multicentre case-control study.

Stagnaro E, Parodi S, Costantini AS, Crosignani P, Miligi L, Nanni O, Piro S, Ramazzotti V, Rodella S, Tumino R, Vindigni C, Vineis P.

Epidemiol Infect. 2018 Sep;146(12):1572-1574. doi: 10.1017/S0950268818001413. Epub 2018 May 30.

PMID:
29843844
7.

Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study.

Mazzei MA, Bagnacci G, Gentili F, Nigri A, Pelini V, Vindigni C, Mazzei FG, Baiocchi GL, Pittiani F, Morgagni P, Petrella E, Mura G, Verdelli B, Bencivenga M, Giacopuzzi S, Marrelli D, Roviello F, Volterrani L.

Gastroenterol Res Pract. 2018 Mar 15;2018:1794524. doi: 10.1155/2018/1794524. eCollection 2018.

8.

An aggressive early gastric cancer: Kodama's PenA type.

Morgagni P, Solaini L, Saragoni L, Bencivenga M, Fumagalli Romario U, Graziosi L, Marino E, Marrelli D, Rausei S, Rosa F, Scarpi E, Tomezzoli A, Tringali D, Vindigni C, Vittimberga G, Roviello F; GIRCG.

Eur J Surg Oncol. 2018 Aug;44(8):1186-1190. doi: 10.1016/j.ejso.2018.03.016. Epub 2018 Mar 27.

PMID:
29628438
9.

Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG).

Saragoni L, Scarpi E, Ravaioli A, Morgagni P, Roviello F, Vindigni C, Rausei S, Chiaravalli AM, Fumagalli U, Spaggiari P, Rosa F, Ricci R, Donini A, Giovenali P, Tomezzoli A, De Manzoni G.

Oncologist. 2018 Jul;23(7):852-858. doi: 10.1634/theoncologist.2017-0488. Epub 2018 Jan 31.

10.

The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients.

Polom K, Marrelli D, Smyth EC, Voglino C, Roviello G, Pascale V, Varas J, Vindigni C, Roviello F.

Surg Innov. 2018 Apr;25(2):99-104. doi: 10.1177/1553350617751461. Epub 2018 Jan 5.

PMID:
29303062
11.

Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series.

Baiocchi GL, Molfino S, Baronchelli C, Giacopuzzi S, Marrelli D, Morgagni P, Bencivenga M, Saragoni L, Vindigni C, Portolani N, Botticini M, De Manzoni G.

World J Gastroenterol. 2017 Dec 7;23(45):8000-8007. doi: 10.3748/wjg.v23.i45.8000.

12.

High-mobility group box protein 1 expression in inflammatory diseases of the middle ear.

Bellussi LM, Vindigni C, Cocca S, Butorano MAGM, Livi W, Corallo G, Passali D.

Int J Immunopathol Pharmacol. 2017 Jun;30(2):168-173. doi: 10.1177/0394632017698713. Epub 2017 Mar 15.

13.

Prognostic Value of Perineural Invasion in Resected Gastric Cancer Patients According to Lauren Histotype.

De Franco L, Marrelli D, Voglino C, Vindigni C, Ferrara F, Di Mare G, Iudici L, Marini M, Roviello F.

Pathol Oncol Res. 2018 Apr;24(2):393-400. doi: 10.1007/s12253-017-0257-8. Epub 2017 May 30.

PMID:
28555306
14.

Single Center Experience on Anatomy-and Histopathology-Based Gastric Cancer Molecular Classification.

Polom K, Marrelli D, Roviello G, Voglino C, Vindigni C, Generali D, Roviello F.

Cancer Invest. 2017 May 28;35(5):325-332. doi: 10.1080/07357907.2017.1292519. Epub 2017 Mar 28.

PMID:
28350490
15.

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.

Lastraioli E, Lottini T, Iorio J, Freschi G, Fazi M, Duranti C, Carraresi L, Messerini L, Taddei A, Ringressi MN, Salemme M, Villanacci V, Vindigni C, Tomezzoli A, La Mendola R, Bencivenga M, Compagnoni B, Chiudinelli M, Saragoni L, Manzi I, De Manzoni G, Bechi P, Boni L, Arcangeli A.

Oncotarget. 2016 Sep 13;7(37):59535-59547. doi: 10.18632/oncotarget.11149.

16.

Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.

Capelli L, Petracci E, Quagliuolo V, Saragoni L, Colombo P, Morgagni P, Calistri D, Tomezzoli A, Di Cosmo M, Roviello F, Vindigni C, Coniglio A, Villanacci V, Catarci M, Coppola L, Alfieri S, Ricci R, Capella C, Rausei S, Gulino D, Amadori D, Ulivi P; Italian Gastric Cancer Research Group (GIRCG).

Eur J Surg Oncol. 2016 Aug;42(8):1206-14. doi: 10.1016/j.ejso.2016.05.022. Epub 2016 May 30.

PMID:
27265040
17.

The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015.

De Manzoni G, Marrelli D, Baiocchi GL, Morgagni P, Saragoni L, Degiuli M, Donini A, Fumagalli U, Mazzei MA, Pacelli F, Tomezzoli A, Berselli M, Catalano F, Di Leo A, Framarini M, Giacopuzzi S, Graziosi L, Marchet A, Marini M, Milandri C, Mura G, Orsenigo E, Quagliuolo V, Rausei S, Ricci R, Rosa F, Roviello G, Sansonetti A, Sgroi G, Tiberio GA, Verlato G, Vindigni C, Rosati R, Roviello F.

Gastric Cancer. 2017 Jan;20(1):20-30. doi: 10.1007/s10120-016-0615-3. Epub 2016 Jun 2.

PMID:
27255288
18.

High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability.

Polom K, Marrelli D, Pascale V, Roviello G, Voglino C, Rho H, Vindigni C, Marini M, Macchiarelli R, Roviello F.

J Cancer Res Clin Oncol. 2016 Aug;142(8):1817-24. doi: 10.1007/s00432-016-2181-9. Epub 2016 May 20.

PMID:
27206556
19.

Reperfusion in non-occlusive mesenteric ischaemia (NOMI): effectiveness of CT in an emergency setting.

Mazzei MA, Guerrini S, Cioffi Squitieri N, Vindigni C, Imbriaco G, Gentili F, Berritto D, Mazzei FG, Grassi R, Volterrani L.

Br J Radiol. 2016;89(1061):20150956. doi: 10.1259/bjr.20150956. Epub 2016 Feb 5.

20.

MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion.

Mariotti S, Barravecchia I, Vindigni C, Pucci A, Balsamo M, Libro R, Senchenko V, Dmitriev A, Jacchetti E, Cecchini M, Roviello F, Lai M, Broccoli V, Andreazzoli M, Mazzanti CM, Angeloni D.

Oncotarget. 2016 Jan 12;7(2):1808-25. doi: 10.18632/oncotarget.6577.

21.

Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer.

Marrelli D, Polom K, Pascale V, Vindigni C, Piagnerelli R, De Franco L, Ferrara F, Roviello G, Garosi L, Petrioli R, Roviello F.

Ann Surg Oncol. 2016 Mar;23(3):943-50. doi: 10.1245/s10434-015-4931-3. Epub 2015 Nov 3.

PMID:
26530444
22.

A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study.

Ambrosio MR, Rocca BJ, Ginori A, Mourmouras V, Amato T, Vindigni C, Lazzi S, Leoncini L.

Am J Clin Pathol. 2015 Nov;144(5):817-22. doi: 10.1309/AJCP2G0VKTKPNPRR.

PMID:
26486748
23.

Histological variety of gastric carcinoma and Helicobacter pylori cagA and vacA polymorphism.

Figura N, Valassina M, Moretti E, Vindigni C, Collodel G, Iacoponi F, Giordano N, Roviello F, Marrelli D.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1017-21. doi: 10.1097/MEG.0000000000000414.

PMID:
26067222
24.

Assessment of a Test for the Screening and Diagnosis of Celiac Disease.

Porcelli B, Ferretti F, Vindigni C, Terzuoli L.

J Clin Lab Anal. 2016 Jan;30(1):65-70. doi: 10.1002/jcla.21816. Epub 2014 Nov 10.

PMID:
25385391
25.

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN.

J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44. doi: 10.1093/jncimonographs/lgu013.

26.

VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohort.

Lastraioli E, Boni L, Romoli MR, Crescioli S, Taddei A, Beghelli S, Tomezzoli A, Vindigni C, Saragoni L, Messerini L, Bernini M, Bencini L, Giommoni E, Freschi G, Di Costanzo F, Scarpa A, Morgagni P, Farsi M, Roviello F, De Manzoni G, Bechi P, Arcangeli A; Gruppo Italiano di Ricerca Cancro Gastrico (GIRCG).

Eur J Surg Oncol. 2014 Oct;40(10):1291-8. doi: 10.1016/j.ejso.2014.03.028. Epub 2014 Apr 12.

PMID:
24784776
27.

hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications.

Crociani O, Lastraioli E, Boni L, Pillozzi S, Romoli MR, D'Amico M, Stefanini M, Crescioli S, Masi A, Taddei A, Bencini L, Bernini M, Farsi M, Beghelli S, Scarpa A, Messerini L, Tomezzoli A, Vindigni C, Morgagni P, Saragoni L, Giommoni E, Gasperoni S, Di Costanzo F, Roviello F, De Manzoni G, Bechi P, Arcangeli A.

Clin Cancer Res. 2014 Mar 15;20(6):1502-12. doi: 10.1158/1078-0432.CCR-13-2633. Epub 2014 Jan 21. Erratum in: Clin Cancer Res. 2014 Aug 1;20(15):4168-9. Clin Cancer Res. 2014 May 1;20(9):2501. Masi, Alessio [added].

28.

Immunolocalisation of ghrelin and obestatin in human testis, seminal vesicles, prostate and spermatozoa.

Moretti E, Vindigni C, Tripodi SA, Mazzi L, Nuti R, Figura N, Collodel G.

Andrologia. 2014;46(9):979-85. doi: 10.1111/and.12183. Epub 2013 Oct 23.

PMID:
24147986
29.

Childhood infectious diseases and risk of leukaemia in an adult population.

Parodi S, Crosignani P, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Tumino R, Vindigni C, Vineis P, Stagnaro E.

Int J Cancer. 2013 Oct 15;133(8):1892-9. doi: 10.1002/ijc.28205. Epub 2013 Jul 6.

30.

Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.

Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C.

J Clin Oncol. 2013 Mar 1;31(7):868-75. doi: 10.1200/JCO.2012.44.4612. Epub 2013 Jan 22.

PMID:
23341533
31.

Detection of autoantibodies against actin filaments in celiac disease.

Porcelli B, Ferretti F, Vindigni C, Scapellato C, Terzuoli L.

J Clin Lab Anal. 2013 Jan;27(1):21-6. doi: 10.1002/jcla.21556. Epub 2013 Jan 4.

PMID:
23292801
32.

Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection.

Figura N, Moretti E, Vaglio L, Langone F, Vernillo R, Vindigni C, Giordano N.

New Microbiol. 2012 Jul;35(3):335-40. Epub 2012 Jun 30.

33.

HLA-DQ typing in the diagnostic algorithm of celiac disease.

Piccini B, Vascotto M, Serracca L, Luddi A, Margollicci MA, Balestri P, Vindigni C, Bassotti G, Villanacci V.

Rev Esp Enferm Dig. 2012 May;104(5):248-54.

34.

Erratum to: Assessment of a combination screening assay for celiac disease.

Porcelli B, Ferretti F, Vindigni C, Scapellato C, Terzuoli L.

Auto Immun Highlights. 2011 Oct 11;3(1):33. doi: 10.1007/s13317-011-0026-8. eCollection 2012 Apr.

35.

Computed tomographic evaluation of mesentery: diagnostic value in acute mesenteric ischemia.

Mazzei MA, Mazzei FG, Marrelli D, Imbriaco G, Guerrini S, Vindigni C, Civitelli S, Roviello F, Grassi R, Volterrani L.

J Comput Assist Tomogr. 2012 Jan-Feb;36(1):1-7. doi: 10.1097/RCT.0b013e31823b4465.

PMID:
22261763
36.

Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.

Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F.

BMC Cancer. 2012 Jan 6;12:8. doi: 10.1186/1471-2407-12-8. Review.

37.

Assessment of a combination screening assay for celiac disease.

Porcelli B, Ferretti F, Vindigni C, Scapellaato C, Terzuoli L.

Auto Immun Highlights. 2011 May 19;2(2):67-71. doi: 10.1007/s13317-011-0020-1. eCollection 2011 Nov. Erratum in: Auto Immun Highlights. 2012 Apr;3(1):33.

38.

Coeliac disease: the histology report.

Villanacci V, Ceppa P, Tavani E, Vindigni C, Volta U; Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP).

Dig Liver Dis. 2011 Mar;43 Suppl 4:S385-95. doi: 10.1016/S1590-8658(11)60594-X.

PMID:
21459344
39.

High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study.

Marrelli D, Mazzei MA, Pedrazzani C, Di Martino M, Vindigni C, Corso G, Morelli E, Volterrani L, Roviello F.

Ann Surg Oncol. 2011 Aug;18(8):2265-72. doi: 10.1245/s10434-010-1541-y. Epub 2011 Jan 26.

PMID:
21267792
40.

Oncogenic mutations in gastric cancer with microsatellite instability.

Corso G, Velho S, Paredes J, Pedrazzani C, Martins D, Milanezi F, Pascale V, Vindigni C, Pinheiro H, Leite M, Marrelli D, Sousa S, Carneiro F, Oliveira C, Roviello F, Seruca R.

Eur J Cancer. 2011 Feb;47(3):443-51. doi: 10.1016/j.ejca.2010.09.008.

PMID:
20937558
41.

Eosinophilic esophagitis: an Italian experience.

Vindigni C, Villanacci V, Marini M, Rocca BJ, Frosini G, Pedruzzi E, Corazzi N, Bassotti G, Tosi P.

Rev Esp Enferm Dig. 2010 Jan;102(1):15-9.

42.

Italy-Japan agreement and discrepancies in diagnosis of superficial gastric lesions.

Vindigni C, Marini M, Cevenini G, Raffaella Ambrosio M, Onorati M, Frosini G, Gotoda T, Taniguchi H, Tosi P.

Front Biosci (Elite Ed). 2010 Jan 1;2:733-8.

PMID:
20036917
43.

Undifferentiated gastric carcinoma with lymphoid stroma (lymphoepithelioma-like carcinoma/medullary carcinoma).

Falzarano SM, Mourmouras V, Mastrogiulio MG, La Magra C, Vindigni C.

Pathologica. 2009 Feb;101(1):15-7.

PMID:
19771767
44.

Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis.

Lazzi S, Bellan C, Onnis A, De Falco G, Sayed S, Kostopoulos I, Onorati M, D'Amuri A, Santopietro R, Vindigni C, Fabbri A, Righi S, Pileri S, Tosi P, Leoncini L.

Hum Pathol. 2009 Sep;40(9):1252-61. doi: 10.1016/j.humpath.2009.01.007. Epub 2009 Apr 14.

PMID:
19368954
45.

Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer.

Marrelli D, Pedrazzani C, Berardi A, Corso G, Neri A, Garosi L, Vindigni C, Santucci A, Figura N, Roviello F.

Cancer. 2009 May 15;115(10):2071-80. doi: 10.1002/cncr.24253.

46.

Activated Akt as an indicator of prognosis in gastric cancer.

Cinti C, Vindigni C, Zamparelli A, La Sala D, Epistolato MC, Marrelli D, Cevenini G, Tosi P.

Virchows Arch. 2008 Nov;453(5):449-55. doi: 10.1007/s00428-008-0676-8. Epub 2008 Oct 8.

PMID:
18841391
47.

Immunohistochemical expression of p53 and Ki67 in colorectal adenomas and prediction of malignancy and development of new polyps.

Vernillo R, Lorenzi B, Banducci T, Minacci C, Vindigni C, Lucenti Fei A, Lorenzi M.

Int J Biol Markers. 2008 Apr-Jun;23(2):89-95.

PMID:
18629781
48.

High incidence of familial gastric cancer in Tuscany, a region in Italy.

Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Suriano G, Vindigni C, Berardi A, Garosi L, De Stefano A, Leoncini L, Seruca R, Pinto E.

Oncology. 2007;72(3-4):243-7. doi: 10.1159/000113015. Epub 2008 Jan 10.

PMID:
18185018
49.

Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease.

Corazza GR, Villanacci V, Zambelli C, Milione M, Luinetti O, Vindigni C, Chioda C, Albarello L, Bartolini D, Donato F.

Clin Gastroenterol Hepatol. 2007 Jul;5(7):838-43. Epub 2007 Jun 4.

PMID:
17544877
50.

Personal use of hair dyes and hematolymphopoietic malignancies.

Miligi L, Costantini AS, Benvenuti A, Veraldi A, Tumino R, Ramazzotti V, Vindigni C, Amadori D, Fontana A, Rodella S, Stagnaro E, Crosignani P, Vineis P.

Arch Environ Occup Health. 2005 Sep-Oct;60(5):249-56.

PMID:
17290845

Supplemental Content

Loading ...
Support Center